STRO · Sutro Biopharma, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-05 | Dybbs Michael |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option shall vest, subject to the reporting person's provision of service to the issuer on each vesting date, as to 8.33% of the total award monthly, with the first tranche vesting on July 5, 2026, and the award shall be fully vested and exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 5, 2027. |
Stock Option (right to buy)
|
10,000 |
| 2026-06-05 | Lobacki Joseph M |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option shall vest, subject to the reporting person's provision of service to the issuer on each vesting date, as to 8.33% of the total award monthly, with the first tranche vesting on July 5, 2026, and the award shall be fully vested and exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 5, 2027. |
Stock Option (right to buy)
|
10,000 |
| 2026-06-05 | Hunter Heidi |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option shall vest, subject to the reporting person's provision of service to the issuer on each vesting date, as to 8.33% of the total award monthly, with the first tranche vesting on July 5, 2026, and the award shall be fully vested and exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 5, 2027. |
Stock Option (right to buy)
|
10,000 |
| 2026-06-05 | PANEK JAMES P |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option shall vest, subject to the reporting person's provision of service to the issuer on each vesting date, as to 8.33% of the total award monthly, with the first tranche vesting on July 5, 2026, and the award shall be fully vested and exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 5, 2027. |
Stock Option (right to buy)
|
10,000 |
| 2026-06-05 | MATSUI CONNIE |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option shall vest, subject to the reporting person's provision of service to the issuer on each vesting date, as to 8.33% of the total award monthly, with the first tranche vesting on July 5, 2026, and the award shall be fully vested and exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 5, 2027. |
Stock Option (right to buy)
|
10,000 |
| 2026-06-05 | Petree Daniel H |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option shall vest, subject to the reporting person's provision of service to the issuer on each vesting date, as to 8.33% of the total award monthly, with the first tranche vesting on July 5, 2026, and the award shall be fully vested and exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 5, 2027. |
Stock Option (right to buy)
|
10,000 |
| 2026-06-05 | Wigginton Jon Marc |
Chief Medical Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option shall vest, subject to the reporting person's provision of service to the issuer on each vesting date, as to 8.33% of the total award monthly, with the first tranche vesting on July 5, 2026, and the award shall be fully vested and exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 5, 2027. |
Stock Option (right to buy)
|
10,000 |
| 2026-06-05 | Jagpal Sukhi |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option shall vest, subject to the reporting person's provision of service to the issuer on each vesting date, as to 8.33% of the total award monthly, with the first tranche vesting on July 5, 2026, and the award shall be fully vested and exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 5, 2027. |
Stock Option (right to buy)
|
10,000 |
| 2026-06-02 | Chow Gregory K. |
Executive VP & CFO |
Convert↑
Filing footnotes — Common Stock (Direct)
For avoidance of doubt, the reporting person elected to satisfy tax withholding liabilities in cash in lieu of withholding shares. The reported total includes 250 shares of Common Stock acquired by the reporting person in one or more transactions with the Issuer pursuant to its employee stock purchase plan, which transactions are exempt pursuant to Rules 16a3(f)(1)(i)(B) and 16b3(c). |
Common Stock
|
2,500 |
| 2026-06-02 | Chow Gregory K. |
Executive VP & CFO |
Convert↓
Filing footnotes — Restricted Stock Units (RSUs) (Direct)
Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. The award vested or vests annually as to 1/4th of the total award, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vested on June 2, 2026. |
Restricted Stock Units (RSUs)
|
2,500 |
| 2026-03-04 | Pauling David |
Chief Admin. Ofcr. & GC |
Convert↑
|
Common Stock
|
675 |
| 2026-03-04 | Chung Jane |
Director, Chief Executive Officer |
Convert↑
|
Common Stock
|
788 |
| 2026-03-04 | Pauling David |
Chief Admin. Ofcr. & GC |
Convert↓
Filing footnotes — Restricted Stock Units (RSUs) (Direct)
Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 4, 2023, subject to continued service through each vesting date. |
Restricted Stock Units (RSUs)
|
675 |
| 2026-03-04 | Pauling David |
Chief Admin. Ofcr. & GC |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person. |
Common Stock
|
277 |
| 2026-03-04 | Chung Jane |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Restricted Stock Units (RSUs) (Direct)
Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 4, 2023, subject to continued service through each vesting date. |
Restricted Stock Units (RSUs)
|
788 |
| 2026-03-04 | Chung Jane |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person. |
Common Stock
|
282 |
| 2026-03-02 | Pauling David |
Chief Admin. Ofcr. & GC |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
1/48 of the total option award shall vest monthly, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on April 1, 2026. |
Stock Option (right to buy)
|
33,600 |
| 2026-03-02 | Chow Gregory K. |
Executive VP & CFO |
Award↑
Filing footnotes — Restricted Stock Units (RSUs) (Direct)
Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. The RSUs shall vest as to 1/4 of the total award annually, with the first tranche vesting on March 1, 2027, subject to continued service through each vesting date. |
Restricted Stock Units (RSUs)
|
5,000 |
| 2026-03-02 | Chung Jane |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person. |
Common Stock
|
2,779 |
| 2026-03-02 | Gerber Hans-Peter |
CHIEF SCIENTIFIC OFFICER |
Convert↑
|
Common Stock
|
2,843 |
| 2026-03-02 | Gerber Hans-Peter |
CHIEF SCIENTIFIC OFFICER |
Award↑
Filing footnotes — Restricted Stock Units (RSUs) (Direct)
Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. The RSUs shall vest as to 1/4 of the total award annually, with the first tranche vesting on March 1, 2027, subject to continued service through each vesting date. |
Restricted Stock Units (RSUs)
|
5,000 |
| 2026-03-02 | Gerber Hans-Peter |
CHIEF SCIENTIFIC OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person. |
Common Stock
|
1,170 |
| 2026-03-02 | Pauling David |
Chief Admin. Ofcr. & GC |
Award↑
Filing footnotes — Restricted Stock Units (RSUs) (Direct)
Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. The RSUs shall vest as to 1/4 of the total award annually, with the first tranche vesting on March 1, 2027, subject to continued service through each vesting date. |
Restricted Stock Units (RSUs)
|
4,200 |
| 2026-03-02 | Chow Gregory K. |
Executive VP & CFO |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
1/48 of the total option award shall vest monthly, subject to the reporting person's continued service through each vesting date, with the first tranche vesting on April 1, 2026. |
Stock Option (right to buy)
|
40,000 |
| 2026-03-02 | Gerber Hans-Peter |
CHIEF SCIENTIFIC OFFICER |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
1/48 of the total option award shall vest monthly, subject to the reporting person's continued service through each vesting date, with the first tranche vesting on April 1, 2026. |
Stock Option (right to buy)
|
40,000 |
| 2026-03-02 | Chung Jane |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
1/48 of the total option award shall vest monthly, subject to the reporting person's continued service through each vesting date, with the first tranche vesting on April 1, 2026. |
Stock Option (right to buy)
|
175,000 |
| 2026-03-02 | Pauling David |
Chief Admin. Ofcr. & GC |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs; does not represent a sale by the reporting person. |
Common Stock
|
970 |
| 2026-03-02 | Chung Jane |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Restricted Stock Units (RSUs) (Direct)
Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. The RSUs shall vest as to 1/4 of the total award annually, with the first tranche vesting on March 1, 2027, subject to continued service through each vesting date. |
Restricted Stock Units (RSUs)
|
40,000 |
| 2026-03-02 | Pauling David |
Chief Admin. Ofcr. & GC |
Convert↓
Filing footnotes — Restricted Stock Units (RSUs) (Direct)
Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 2, 2026, subject to continued service through each vesting date. |
Restricted Stock Units (RSUs)
|
2,356 |
| 2026-03-02 | Pauling David |
Chief Admin. Ofcr. & GC |
Convert↑
|
Common Stock
|
2,356 |
| 2026-03-02 | Chung Jane |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Restricted Stock Units (RSUs) (Direct)
Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 2, 2026, subject to continued service through each vesting date. |
Restricted Stock Units (RSUs)
|
7,750 |
| 2026-03-02 | Chung Jane |
Director, Chief Executive Officer |
Convert↑
|
Common Stock
|
7,750 |
| 2026-03-02 | Gerber Hans-Peter |
CHIEF SCIENTIFIC OFFICER |
Convert↓
Filing footnotes — Restricted Stock Units (RSUs) (Direct)
Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 2, 2026, subject to continued service through each vesting date. |
Restricted Stock Units (RSUs)
|
2,843 |
| 2026-03-01 | Chung Jane |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person. |
Common Stock
|
1,271 |
| 2026-03-01 | Pauling David |
Chief Admin. Ofcr. & GC |
Convert↓
Filing footnotes — Restricted Stock Units (RSUs) (Direct)
Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 1, 2024, subject to continued service through each vesting date. |
Restricted Stock Units (RSUs)
|
500 |
| 2026-03-01 | Gerber Hans-Peter |
CHIEF SCIENTIFIC OFFICER |
Convert↑
|
Common Stock
|
1,125 |
| 2026-03-01 | Chung Jane |
Director, Chief Executive Officer |
Convert↑
|
Common Stock
|
688 |
| 2026-03-01 | Pauling David |
Chief Admin. Ofcr. & GC |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs; does not represent a sale by the reporting person. |
Common Stock
|
551 |
| 2026-03-01 | Gerber Hans-Peter |
CHIEF SCIENTIFIC OFFICER |
Convert↓
Filing footnotes — Restricted Stock Units (RSUs) (Direct)
Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 1, 2025, subject to continued service through each vesting date. |
Restricted Stock Units (RSUs)
|
1,125 |
| 2026-03-01 | Chung Jane |
Director, Chief Executive Officer |
Convert↑
|
Common Stock
|
2,500 |
| 2026-03-01 | Pauling David |
Chief Admin. Ofcr. & GC |
Convert↓
Filing footnotes — Restricted Stock Units (RSUs) (Direct)
Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 1, 2025, subject to continued service through each vesting date. |
Restricted Stock Units (RSUs)
|
842 |
| 2026-03-01 | Chung Jane |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Restricted Stock Units (RSUs) (Direct)
Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 1, 2024, subject to continued service through each vesting date. |
Restricted Stock Units (RSUs)
|
688 |
| 2026-03-01 | Pauling David |
Chief Admin. Ofcr. & GC |
Convert↑
|
Common Stock
|
500 |
| 2026-03-01 | Chung Jane |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Restricted Stock Units (RSUs) (Direct)
Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 1, 2025, subject to continued service through each vesting date. |
Restricted Stock Units (RSUs)
|
2,500 |
| 2026-03-01 | Pauling David |
Chief Admin. Ofcr. & GC |
Convert↑
|
Common Stock
|
842 |
| 2026-03-01 | Gerber Hans-Peter |
CHIEF SCIENTIFIC OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person. |
Common Stock
|
463 |
| 2025-12-23 | Jagpal Sukhi |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option shall vest as to 16.67% of the total award monthly, subject to the reporting person's continued service to the issuer on each vesting date, with the first tranche vesting on January 23, 2026. |
Stock Option (right to buy)
|
1,500 |
| 2025-12-23 | Gerber Hans-Peter |
CHIEF SCIENTIFIC OFFICER |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
1/48 of the total option award shall vest monthly, subject to the reporting person's continued service to the issuer on each vesting date, with the first tranche vesting on January 23, 2026. |
Stock Option (right to buy)
|
7,925 |
| 2025-12-23 | Hunter Heidi |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option shall vest as to 16.67% of the total award monthly, subject to the reporting person's continued service to the issuer on each vesting date, with the first tranche vesting on January 23, 2026. |
Stock Option (right to buy)
|
1,500 |
| 2025-12-23 | Pauling David |
Chief Admin. Ofcr. & GC |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
1/48 of the total option award shall vest monthly, subject to the reporting person's continued service to the issuer on each vesting date, with the first tranche vesting on January 23, 2026. |
Stock Option (right to buy)
|
7,200 |